Helio in the News
Patient services programs and the associated risks across the life sciences industry vary in shape and style, especially as the government is beginning to heavily investigate the activities conducted by manufacturers in this area. This article highlights some of the differences in the industry as seen through an annual patient services compliance survey conducted by Helio Health Group.
Point of view report written on the future of patient support programs in light of recent government scrutiny
Pharma manufacturer to pay $210 million settlement to resolve charges of paying kickbacks to Medicare patients through an independent charity: Helio comments on how this settlement can be used for effective monitoring
Regulators are beginning to look at the organ drug market and the commercial and marketing practices. Helio provides commentary on the importance of compliance programs
First physicians, now patients: Risk avoidance in patient support programs - Helio illustrates the growing risk areas for patient services programs and how to mitigate potential risks
Nurses hired by pharma companies are receiving greater scrutiny, toeing the line between educators and marketers.
Pharma charity under fire for letting drug makers access data: Helio weighs in on the risks associated with pharma donations to charities
The under-regulated world of patient services: Helio Health's survey illustrating the need for Pharma to implement better internal policies to manage its increasing patient interaction
"Here’s how a loophole in a transparency law can distort medical practices": Helio provides insight into industry practices